LeadIQ logo
Learn more at LeadIQ.com

Insights

Strategic Collaborations Adagene has established partnerships with major biotech firms like Sanofi and Incyte, validating its pipeline and opening avenues for licensing, co-development, and royalty revenue streams that can be leveraged for expanding sales efforts.

Innovative Platform Powered by its proprietary DPL platform with technologies like NEObody, SAFEbody, and POWERbody, Adagene offers advanced antibody development solutions, positioning it as a potential partner for organizations seeking cutting-edge immunotherapy collaborations.

Pipeline Progression With upcoming data releases from key assets like ADG126 and Muzastotug, Adagene presents opportunities for value-driven partnerships and licensing deals, especially as clinical milestones approach that can attract industry interest.

Funding Momentum Recent successful public offerings of ADSs and substantial funding round have strengthened Adagene’s financial position, making it more attractive for joint ventures, co-investments, and strategic alliances in the biotech sector.

Industry Focus Adagene's specialization in antibody-based oncology therapies and its position within a competitive landscape of biotech firms with similar market focus suggests opportunities for targeted sales efforts towards research institutions and pharma companies seeking novel immunotherapeutic candidates.

Adagene Tech Stack

Adagene uses 8 technology products and services including oEmbed, Microsoft Outlook, jQuery Migrate, and more. Explore Adagene's tech stack below.

  • oEmbed
    Dev Tools
  • Microsoft Outlook
    Email
  • jQuery Migrate
    Javascript Libraries
  • Modernizr
    Javascript Libraries
  • DataTables
    Javascript Libraries
  • Microsoft Office
    Office Suites
  • Onsen UI
    Software Development
  • RankMath SEO
    Web Platform Extensions

Media & News

Adagene's Email Address Formats

Adagene uses at least 1 format(s):
Adagene Email FormatsExamplePercentage
First_Last@adagene.comJohn_Doe@adagene.com
92%
Last@adagene.comDoe@adagene.com
5%
LastFir@adagene.comDoeJoh@adagene.com
3%

Frequently Asked Questions

Where is Adagene's headquarters located?

Minus sign iconPlus sign iconAdagene's main headquarters is located at 218 C14 Wuzhong District, Xiangcheng District, Parts of Suzhou New District And Parts of Suzhou Industrial Park, Jiangsu 215123 China. The company has employees across 3 continents, including AsiaNorth AmericaEurope.

What is Adagene's phone number?

Minus sign iconPlus sign icon You can contact Adagene's main corporate office by phone at
+86-512-8777-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Adagene's stock symbol?

Minus sign iconPlus sign iconAdagene is a publicly traded company; the company's stock symbol is ADAG.

What is Adagene's official website and social media links?

Minus sign iconPlus sign iconAdagene's official website is adagene.com and has social profiles on LinkedInCrunchbase.

What is Adagene's SIC code NAICS code?

Minus sign iconPlus sign iconAdagene's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Adagene have currently?

Minus sign iconPlus sign iconAs of June 2026, Adagene has approximately 83 employees across 3 continents, including AsiaNorth AmericaEurope. Key team members include Chief Strategy Officer: M. C.Chief Financial Officer: R. T.Chief Technology Officer: F. D.. Explore Adagene's employee directory with LeadIQ.

What industry does Adagene belong to?

Minus sign iconPlus sign iconAdagene operates in the Biotechnology Research industry.

What technology does Adagene use?

Minus sign iconPlus sign iconAdagene's tech stack includes oEmbedMicrosoft OutlookjQuery MigrateModernizrDataTablesMicrosoft OfficeOnsen UIRankMath SEO.

What is Adagene's email format?

Minus sign iconPlus sign iconAdagene's email format typically follows the pattern of First_Last@adagene.com. Find more Adagene email formats with LeadIQ.

How much funding has Adagene raised to date?

Minus sign iconPlus sign icon As of June 2026, Adagene has raised $25M in funding. The last funding round occurred on Jul 01, 2025 for $25M.

When was Adagene founded?

Minus sign iconPlus sign iconAdagene was founded in 2012.

Adagene

Biotechnology ResearchJiangsu, China51-200 Employees

Adagene Inc. is a biotechnology company focused on the discovery and development of antibody-based cancer immunotherapies. It combines computational biology and artificial intelligence to design novel antibodies, powered by its proprietary DPL platform, which includes NEObody, SAFEbody, and POWERbody technologies. The company is based in Suzhou, Jiangsu, China, with a location spanning the Wuzhong and Xiangcheng districts and areas within Suzhou New District and Suzhou Industrial Park. Adagene maintains a differentiated pipeline of immunotherapy programs and has established strategic collaborations with global partners to leverage its technology. It is listed on Nasdaq under the ticker ADAG and reports revenue in the tens of millions of dollars, with about $25 million in funding.

Section iconCompany Overview

Headquarters
218 C14 Wuzhong District, Xiangcheng District, Parts of Suzhou New District And Parts of Suzhou Industrial Park, Jiangsu 215123 China
Phone number
+86-512-8777-****
Website
adagene.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
ADAG
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2012
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $25M

    Adagene has raised a total of $25M of funding over 7 rounds. Their latest funding round was raised on Jul 01, 2025 in the amount of $25M.

  • $10M$25M

    Adagene's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $25M

    Adagene has raised a total of $25M of funding over 7 rounds. Their latest funding round was raised on Jul 01, 2025 in the amount of $25M.

  • $10M$25M

    Adagene's revenue is estimated to be in the range of $10M$25M

Company Leadership

  • Stylized image of a person
    M. C.
    Chief Strategy Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    R. T.
    Chief Financial Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    F. D.
    Chief Technology Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    L. C.
    Vp Clinical Development
    Phone icon
    Mobile Phone
  • Stylized image of a person
    W. Z.
    Vice President Of Early Stage Cmc
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    W. Z.
    Vice President Of Early Stage Cmc
    Phone icon
    Mobile Phone
  • Stylized image of a person
    Y. Z.
    Executive Director [legal And Compliance]
    Phone icon
    Mobile Phone
  • Stylized image of a person
    N. W.
    Associate Director For Toxicology And Dmpk
    Phone icon
    Mobile Phone
  • Stylized image of a person
    X. C.
    Senior Director
    Phone icon
    Mobile Phone
  • Stylized image of a person
    X. C.
    Program Director, Global Drug Product/Pipeline Program Managment
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.